Focusing the analysis on the cancer types investigated in our study, we found no RNPC3 mutations in 1950 AML samples, and only 0.1% (3 out of 3038) of HCC samples, 0.11% (6/5312) of lung adenocarcinomas and 0.32% (2/630) of gastric adenocarcinomas contain a mutation of unknown significance. This evidence concerns the gene RNPC3 and cancer.